HMG-CoA reductase inhibitors: Myopathy in patients with genetic mutations: 4 case reports

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1199, 2008-01, pp. : 27-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HMG-CoA reductase inhibitors/paracetamol: Liver failure: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1202, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

HMG-CoA reductase inhibitors: Muscular disorders: 8 case reports

Reactions Weekly, Vol. 1, Iss. 1174, 2007-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

Oxidation Injury in Patients Receiving HMG-CoA Reductase Inhibitors: Occurrence in Patients Without Enzyme Elevation or Myopathy

By Sinzinger H.

Drug Safety, Vol. 25, Iss. 12, 2002-01 ,pp. : 877-883

Adis International

Access to resources Recommend Favorite

HMG-CoA reductase inhibitors: First report of decreased libido with atorvastatin, fluvastatin, pravastatin and simvastatin: 8 case reports

Reactions Weekly, Vol. 1, Iss. 1039, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

HMG-CoA reductase inhibitors: Nasal polyps (first report with atorvastatin and simvastatin): 3 case reports

Reactions Weekly, Vol. 1, Iss. 1047, 2005-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite